Tehran University of Medical Sciences

Science Communicator Platform

Share By
Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review Publisher Pubmed



Mohseni Afshar Z1 ; Barary M2, 3 ; Hosseinzadeh R4 ; Alijanpour A5 ; Hosseinzadeh D6 ; Ebrahimpour S7 ; Nazary K4 ; Sio TT8 ; Sullman MJM9, 10 ; Carsonchahhoud K11 ; Babazadeh A7
Authors

Source: Human Vaccines and Immunotherapeutics Published:2022


Abstract

At the beginning of the current pandemic, it was believed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection would induce lifelong immunity and that reinfections would be unlikely. However, after several cases of reinfection were documented in previously infected patients, this was understood to be a false assumption, and this waning humoral immunity has raised significant concerns. Accordingly, long-term and durable vaccine-induced antibody protection against infection have also become a challenge, as several breakthroughs of COVID-19 infection have been identified in individuals who were fully vaccinated. This review discusses the current evidence on breakthrough COVID-19 infections occurring after vaccination. © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.
Other Related Docs
9. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
13. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
14. Potential Role of Interferons in Treating Covid-19 Patients, International Immunopharmacology (2021)
19. A Review of Virus-Like Particle-Based Sars-Cov-2 Vaccines in Clinical Trial Phases, Iranian Journal of Pharmaceutical Research (2022)